Descartes-08 for patients with Systemic Lupus Erythematosus Sponsor Name: Cartesian Therapeutics Purpose of Study: This study is being conducted to evaluate the safety, tolerability, and ability to ...

A new study looked at the possibility of a causal relationship between interleukin-18 (IL-18) cytokine and the risk of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE).